Overview
Reactive follicular hyperplasia in the elderly refers to an exaggerated immune response characterized by an increased number of follicles in lymphoid tissues, often mimicking neoplastic processes but lacking the genetic alterations seen in malignancy 1.Diagnosis
Histopathological Examination: Essential for identifying follicular hyperplasia through lymph node biopsy or other tissue sampling 1.
Molecular Testing: Polymerase chain reaction (PCR) specific for bcl-2/JH rearrangements can differentiate reactive hyperplasia from follicular lymphoma; absence of these rearrangements supports a benign process 1.
Differential Diagnosis: Exclude follicular lymphoma by ruling out bcl-2/JH translocations, which are typically absent in reactive hyperplasia 1.Management
Observation: Often sufficient for asymptomatic cases, monitoring for changes in clinical status or imaging findings 1.
Symptomatic Relief: Address underlying causes or symptoms as needed, such as pain management or treatment of infections 1.Special Populations
Elderly: Increased vigilance is warranted due to higher prevalence of comorbidities and atypical presentations; molecular testing can be particularly helpful in this population to rule out malignancy 1.Key Recommendations
Perform molecular testing for bcl-2/JH rearrangements to distinguish reactive follicular hyperplasia from follicular lymphoma in elderly patients (Evidence: Moderate 1).
Consider histopathological examination as the primary diagnostic tool for confirming reactive follicular hyperplasia (Evidence: Strong 1).
Monitor elderly patients closely for clinical changes and consider adjunctive treatments based on symptomatology rather than the hyperplasia itself (Evidence: Expert opinion 1).References
1 Limpens J, de Jong D, van Krieken JH, Price CG, Young BD, van Ommen GJ et al.. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991. link